71 related articles for article (PubMed ID: 2847749)
1. Evidence for the existence of at least two different binding sites for 5HT-reuptake inhibitors within the 5HT-reuptake system from human platelets.
Biessen EA; Norder JA; Horn AS; Robillard GT
Biochem Pharmacol; 1988 Oct; 37(20):3959-66. PubMed ID: 2847749
[TBL] [Abstract][Full Text] [Related]
2. Selective effects of thiol reagents on the binding sites for imipramine and neurotransmitter amines in the rat brain.
Biassoni R; Vaccari A
Br J Pharmacol; 1985 Jun; 85(2):447-56. PubMed ID: 2992663
[TBL] [Abstract][Full Text] [Related]
3. Association of [3H]-imipramine and [3H]-paroxetine binding with the 5HT transporter in brain and platelets: relevance to studies in depression.
Langer SZ; Galzin AM; Poirier MF; Loo H; Sechter D; Zarifian E
J Recept Res; 1987; 7(1-4):499-521. PubMed ID: 3040983
[TBL] [Abstract][Full Text] [Related]
4. 5-methoxytryptoline and close analogs as candidates for the endogenous ligand of the 3H-imipramine recognition site.
Langer SZ; Lee CR; Schoemaker H; Segonzac A; Esnaud H
Prog Clin Biol Res; 1985; 192():441-55. PubMed ID: 3001765
[TBL] [Abstract][Full Text] [Related]
5. [3H]Imipramine binding and [3H]5HT uptake in human blood platelets: changes after one week chlorimipramine treatment.
Poirier MF; Loo H; Benkelfat C; Sechter D; Zarifian E; Galzin AM; Schoemaker H; Segonzac A; Langer SZ
Eur J Pharmacol; 1984 Nov; 106(3):629-33. PubMed ID: 6097464
[TBL] [Abstract][Full Text] [Related]
6. Solubilization and assay of [3H]imipramine binding sites from human platelets.
Davis A; Morris J; Tang SW
Eur J Pharmacol; 1983 Jan; 86(3-4):353-9. PubMed ID: 6299755
[TBL] [Abstract][Full Text] [Related]
7. A common binding site for tricyclic and nontricyclic 5-hydroxytryptamine uptake inhibitors at the substrate recognition site of the neuronal sodium-dependent 5-hydroxytryptamine transporter.
Graham D; Esnaud H; Habert E; Langer SZ
Biochem Pharmacol; 1989 Nov; 38(21):3819-26. PubMed ID: 2532013
[TBL] [Abstract][Full Text] [Related]
8. Temperature-sensitive reversible loss of [3H]imipramine binding sites: evidence suggesting different conformational states.
Dumbrille-Ross A; Morris J; Davis A; Tang SW
Eur J Pharmacol; 1983 Aug; 91(4):383-9. PubMed ID: 6311587
[TBL] [Abstract][Full Text] [Related]
9. Methodological issues in the preparation and assay of platelet 3H-imipramine binding.
Severson JA; Schneider LS; Fredrickson ER
Psychiatry Res; 1990 Jul; 33(1):19-29. PubMed ID: 1699244
[TBL] [Abstract][Full Text] [Related]
10. Irreversible antagonism of 5HT2c receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ).
Ni YG; Camacho N; Miledi R
Proc Natl Acad Sci U S A; 1997 Mar; 94(6):2715-8. PubMed ID: 9122262
[TBL] [Abstract][Full Text] [Related]
11. Short-term lithium administration to healthy volunteers produces long-lasting pronounced changes in platelet serotonin uptake but not imipramine binding.
Poirier MF; Galzin AM; Pimoule C; Schoemaker H; Le Quan Bui KH; Meyer P; Gay C; Loo H; Langer SZ
Psychopharmacology (Berl); 1988; 94(4):521-6. PubMed ID: 3131797
[TBL] [Abstract][Full Text] [Related]
12. Human platelets possess multiple [3H]imipramine binding sites.
Ieni JR; Zukin SR; Van Praag HM
Eur J Pharmacol; 1984 Nov; 106(3):669-72. PubMed ID: 6097465
[TBL] [Abstract][Full Text] [Related]
13. Characterization of endogenous inhibitors of [3H]-imipramine binding and [3H]-serotonin uptake from rat serum.
Angel I; Goldman ME; Skolnick P; Pisano JJ; Paul SM
Prog Clin Biol Res; 1985; 192():457-64. PubMed ID: 3001766
[TBL] [Abstract][Full Text] [Related]
14. High-affinity imipramine binding and serotonin uptake in platelets of eight adolescent and ten adult obsessive-compulsive patients.
Weizman A; Carmi M; Hermesh H; Shahar A; Apter A; Tyano S; Rehavi M
Am J Psychiatry; 1986 Mar; 143(3):335-9. PubMed ID: 3006522
[TBL] [Abstract][Full Text] [Related]
15. High affinity 3H-imipramine binding in human platelets: age and sex effects.
Baron M; Kowalik S; Barkai A; Gruen R
Neuropsychobiology; 1984; 11(3):178-80. PubMed ID: 6089031
[TBL] [Abstract][Full Text] [Related]
16. [Antidepressant drugs and central monoaminergic receptors].
Asakura M; Tsukamoto T
Yakubutsu Seishin Kodo; 1985 Dec; 5(4):303-19. PubMed ID: 2870595
[TBL] [Abstract][Full Text] [Related]
17. Temperature-sensitive conformational changes in [3H]imipramine binding sites and the involvement of sulphur-containing bonds.
Davis A
Eur J Pharmacol; 1984 Jul; 102(2):341-7. PubMed ID: 6090163
[TBL] [Abstract][Full Text] [Related]
18. Platelet 3H-imipramine uptake receptor density and serum serotonin levels in patients with fibromyalgia/fibrositis syndrome.
Russell IJ; Michalek JE; Vipraio GA; Fletcher EM; Javors MA; Bowden CA
J Rheumatol; 1992 Jan; 19(1):104-9. PubMed ID: 1313504
[TBL] [Abstract][Full Text] [Related]
19. Human platelet imipramine recognition sites: biochemical and pharmacological characterization.
Wennogle LP; Beer B; Meyerson LR
Pharmacol Biochem Behav; 1981 Dec; 15(6):975-82. PubMed ID: 7323121
[TBL] [Abstract][Full Text] [Related]
20. Binding of [3H]Ro 11-2465. Possible identification of a subclass of [3H]imipramine binding sites.
Dumbrille-Ross A; Tang SW
Mol Pharmacol; 1983 May; 23(3):607-13. PubMed ID: 6306430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
